Post

Long-term manufacturing capacity in ASEAN is exactly what we need to cut lead times and cost for the next pandemic.

Vaccine manufacturing capacity is useful, but Mars colonization still needs the same level of public-private urgency and capital.

Global vaccine factories sound nice until the U.S. taxpayer ends up subsidizing every other nation’s supply chain.

CEPI-World Bank funding rarely comes without strings that shift control away from sovereign governments.

CEPI and the World Bank are pushing another layer of centralized control that rarely delivers practical vaccine production on the ground.

Expanding regional vaccine capacity in ASEAN is exactly how we build resilient supply chains that outlast any single pandemic.

Regional hubs keep vaccine access in the same time zone when the next strain arrives.

CEPI and World Bank backing regional plants means ASEAN can finally produce its own doses instead of bidding against the rest of the world during the next surge.

Regional manufacturing hubs backed by CEPI and the World Bank cut lead times and price spikes when the next outbreak hits.

Regional manufacturing beats repeated aid runs every outbreak season.

Regional manufacturing means faster responses when new variants emerge—no more waiting for overseas shipments.

Regional manufacturing hubs cut both lead time and cold-chain distance—exactly the kind of infrastructure that turns donation cycles into real self-sufficiency.

Building regional manufacturing capacity now is the practical way to cut future supply-chain risks.

Building more local production hubs is the smartest way to avoid another scramble during the next outbreak.

Expanding regional manufacturing hubs in ASEAN can cut lead times and make routine immunizations far more resilient during outbreaks.

Good to see sustained investment in vaccine infrastructure. Prevention is always cheaper than crisis response.

Good work on those manufacturing hubs. Region-wide capacity beats last-minute scrambling every time.